These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27956640)

  • 1. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.
    Wang AC; Jensen EH; Rexach JE; Vinters HV; Hsieh-Wilson LC
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15120-15125. PubMed ID: 27956640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
    Yuzwa SA; Vocadlo DJ
    Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
    Ryu IH; Lee KY; Do SI
    Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
    Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
    Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders.
    Balana AT; Pratt MR
    Biochem J; 2021 Jul; 478(14):2733-2758. PubMed ID: 34297044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging link between O-GlcNAc and Alzheimer disease.
    Zhu Y; Shan X; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2014 Dec; 289(50):34472-81. PubMed ID: 25336656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
    El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
    Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
    Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
    Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic model to study
    St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA
    J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of Xixin decoction on enzymes related to O-GlcNAc glycosylation of tau proteins in the brain of rats with sporadic Alzheimer's disease].
    Diwu Y; Tian J; Shi J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1442-7. PubMed ID: 24144743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
    Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
    J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation of protein kinase A catalytic subunits enhances its activity: a mechanism linked to learning and memory deficits in Alzheimer's disease.
    Xie S; Jin N; Gu J; Shi J; Sun J; Chu D; Zhang L; Dai CL; Gu JH; Gong CX; Iqbal K; Liu F
    Aging Cell; 2016 Jun; 15(3):455-64. PubMed ID: 26840030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
    Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
    Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc cycling: implications for neurodegenerative disorders.
    Lazarus BD; Love DC; Hanover JA
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2134-46. PubMed ID: 19782947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient regulation of signaling and transcription.
    Hart GW
    J Biol Chem; 2019 Feb; 294(7):2211-2231. PubMed ID: 30626734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.